To the Editor In a recent issue of JAMA Internal Medicine, an Original Investigation by Young et al1 reports the results of a randomized clinical study wherein use of daily self-monitoring of blood glucose failed to improve glycated hemoglobin (HbA1c) levels compared with the study’s control participants. Young et al1 conclude that glucose monitoring in patients with non–insulin-treated type 2 diabetes should not be routine, and Figure 1 shows a reduction of HbA1c by 0.35% in patients using self-monitoring of blood glucose after 6 months. Glycated hemoglobin levels gradually returned to baseline levels by 1 year, but 33% of study participants had stopped monitoring after 6 months while 40% to 60% stopped monitoring after 1 year.1 If half the participants did not adhere to the intervention, a sustained response should not have been expected, especially with the well-known progression of glucose intolerance in type 2 diabetes.
Pimazoni-Netto A, Rodbard D. Concerns About Conclusions of Self-monitoring of Blood Glucose. JAMA Intern Med. 2017;177(12):1873–1874. doi:10.1001/jamainternmed.2017.6142
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: